Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611073 · ClinicalTrials.gov registry record
Maximizing Visual Outcomes With Eyhance IOLs
A clinical trial, sponsored by Berkeley Eye Center.
- Completed
- Registry status
- 110
- Enrollment target
NCT05611073 is a clinical trial that has completed, run by Berkeley Eye Center. The registered enrollment target is 110 participants.
The verdict
NCT05611073 has completed, sponsored by Berkeley Eye Center.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
This is a non-interventional prospective, single center, bilateral, non-randomized, open-label, observational clinical study. All patients will have had bilateral implantation of an Eyhance IOL at the time of cataract surgery. These patients will then be compared to assess which patient biometric properties (such as spherical aberration, q value, pupil size, etc.) lead to an overall increase in near or intermediate vision as well as overall patient satisfaction.
Interventions
- DIAGNOSTIC_TEST Visual Acuity
- DIAGNOSTIC_TEST Biometric Data Collection
- OTHER Patient Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2022-03-07 |
| Est. Completion | 2022-11-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05611073
The ClinicalTrials.gov registry entry for NCT05611073 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Berkeley Eye Center, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Visual Acuity is the first listed.
NCT05611073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05611073 about?
NCT05611073 is a clinical study titled "Maximizing Visual Outcomes With Eyhance IOLs". This is a non-interventional prospective, single center, bilateral, non-randomized, open-label, observational clinical study. All patients will have had bilateral implantation of an Eyhance IOL at the time of cataract surgery. These patients will then be compared to assess which patient biometric pr...
What is the current status of trial NCT05611073?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2022-03-07. Estimated completion is 2022-11-07.
What interventions are being tested in trial NCT05611073?
The interventions under investigation include: Visual Acuity (DIAGNOSTIC_TEST), Biometric Data Collection (DIAGNOSTIC_TEST), Patient Questionnaire (OTHER).
Who is sponsoring clinical trial NCT05611073?
This trial is sponsored by Berkeley Eye Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.